News APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF) Staff September 11, 2023 Iframe sync Post navigation Previous: Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of DirectorsNext: Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T Relapse More Stories Clinical Trial Healthcare News Pharmaceutical Marijuana Rescheduling Makes Strange Bedfellows: MMJ and State Operators Take Their Battles to Federal Court Staff November 21, 2026 Diagnostics EHR Healthcare immunotherapy News ModuleMD Continues to Strengthen Its Position in Allergy EHR Innovation with a New Generation of AI-Powered Technology Staff November 21, 2026 Healthcare News Pharmaceutical FlatRx Publishes a Dated Price Comparison of Compounded Tirzepatide at 27 U.S. Telehealth Programs Counted at a 10 mg Weekly Dose Staff November 21, 2026